
Intersect ENT, Inc. XENT
Intersect ENT, Inc. Betriebsaufwand 2011-2026 | XENT
Betriebsaufwand Jährlich Intersect ENT, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 118 M | 133 M | 111 M | 98.4 M | 91.8 M | 76.2 M | 46.4 M | 27.7 M | 18.5 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 133 M | 18.5 M | 80.1 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
614 M | $ 14.07 | 0.21 % | $ 2.11 B | ||
|
Cognyte Software Ltd.
CGNT
|
293 M | $ 6.86 | 3.63 % | $ 493 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 13.12 | -13.44 % | $ 355 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
AxoGen
AXGN
|
121 M | $ 31.16 | -0.21 % | $ 1.43 B | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 4.49 | -2.18 % | $ 167 M | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.4 | -0.58 % | $ 118 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Electromed
ELMD
|
40.3 M | $ 24.27 | 2.1 % | $ 205 M | ||
|
Bio-Rad Laboratories
BIO
|
1.03 B | $ 269.99 | 0.13 % | $ 7.62 B | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
1.4 B | $ 40.1 | 0.53 % | $ 5.98 K | ||
|
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
10.2 B | $ 74.86 | 1.87 % | $ 111 B | ||
|
InMode Ltd.
INMD
|
136 M | $ 14.01 | 0.32 % | $ 906 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
IRadimed Corporation
IRMD
|
34.4 M | $ 101.93 | 1.42 % | $ 1.29 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 46.53 | 1.2 % | $ 1.44 B | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
697 M | $ 70.52 | 0.33 % | $ 3.85 B | ||
|
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | ||
|
Medtronic PLC
MDT
|
15.3 B | $ 96.9 | 0.25 % | $ 125 B | ||
|
MiMedx Group
MDXG
|
277 M | $ 5.07 | -4.06 % | $ 749 M | ||
|
Delcath Systems
DCTH
|
43.4 M | $ 9.12 | -10.68 % | $ 260 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
60 M | $ 2.44 | -0.41 % | $ 143 M | ||
|
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | ||
|
Establishment Labs Holdings
ESTA
|
160 M | $ 75.24 | -3.9 % | $ 2.12 B | ||
|
Insulet Corporation
PODD
|
531 M | $ 251.19 | 1.24 % | $ 17.7 B | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Quanterix Corporation
QTRX
|
120 M | $ 6.11 | -2.86 % | $ 230 M | ||
|
FONAR Corporation
FONR
|
28.7 M | $ 18.55 | -0.19 % | $ 122 M | ||
|
Sintx Technologies
SINT
|
15.2 M | $ 2.9 | -1.36 % | $ 10.8 M | ||
|
Globus Medical
GMED
|
547 M | $ 95.66 | -0.58 % | $ 12.9 B |